GILD and BIIB Related Headlines
Go Back- Barclays launches U.S. biopharma coverage with four preferred picks
- 4Q25/2026 Biotech Earnings Preview: RBC
- Where can biotech stocks go from here? RBC answers
- Biotech stocks: Q3 earnings preview
- Biotech stocks dip as Trump administration mulls patent fee overhaul
- U.S. large biotech stocks Q2 earnings preview
- Jefferies: 'We highlight multiple de-risked or commercial-stage names that we think have promising M&A potential'
